What We Provide?

• Physical and chemical parameters (such as particle size, particle size distribution, zeta potential, and physical stability) identified as critical quality attributes (CQAs)
• Liposomes contains and free drugs substance
• Total drug substance content
• Degradation products related to lipids (such as hemolyzed lipids) or drug substances
• Lipid content (proves consistency with expected formulation)
• Residual solvents (if any) used in the production of liposome products
• In vitro release of drugs from liposome drug products